|
The Immunohistochemistry Antibody Company
|
|
|
Skin Cancer Screen 32 Tissue Microarray - LS-SSKCA32This tissue microarray is available for use in LSBio Immunohistochemistry Studies only. |
| Catalog ID: | LS-SSKCA32 |
| Product Name: | Skin Cancer Screen 32 |
| Description: | Skin cancer and normal/non-neoplastic skin |
| Format: | FFPE |
| Category: | Human Tumor and Normal |
| QA/QC: | H&E reviewed; IHC validated with a positive control antibody |
| Storage: | Short term RT; Long term 4ºC |
| Clinical History: | No |
| Tissue Marker: | No |
| Stage/Grade: | Yes |
| Core Diameter: | 1.5 mm |
| Core Thickness: | 4 µm |
| Cases: | 48 |
| Cores: | 96 |
| Slides Per Set: | 1 |
LS-SSKCA32 Tissue Microarray Map
Slide Number 1
| LABEL |
|
Diagnosis Type Legend
| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue Legend
Chest (Che); Leg (Leg); Lymph node, Neck (Lym); Penis (Pen); Scalp (Sca); Skin (Skn); Skin, Chest (Skn); Skin, Ear (Skn); Skin, Face (Skn); Skin, Foot (Skn); Skin, Groin (Skn); Skin, Head (Skn); Skin, Leg (Skn); Skin, Penis (Skn); Skin, Trunk (Skn); Skin, Wrist (Skn); Subcutaneous tissue (Sct); Vulva (Vul);
LS-SSKCA32 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type | TNM Tumor Classification | Tumor Grade |
|---|---|---|---|---|---|---|---|---|---|
| 1 | A1 | Human | M | 53 y | Skin, Penis (Skn) | Normal | Benign non-neoplastic | ||
| 1 | A2 | Human | F | 15 y | Skin, Leg (Skn) | Normal | Benign non-neoplastic | ||
| 1 | A3 | Human | M | 57 y | Skin, Wrist (Skn) | Ulcer, Chronic | Inflammatory | ||
| 1 | A4 | Human | F | 48 y | Skin, Ear (Skn) | Polyp | Tumor | ||
| 1 | A5 | Human | F | 20 y | Vulva (Vul) | Warts, HPV positive | Diseased | ||
| 1 | A6 | Human | M | 17 y | Penis (Pen) | Warts, HPV positive | Diseased | ||
| 1 | A7 | Human | M | 25 y | Skin (Skn) | Granuloma | Inflammatory | ||
| 1 | A8 | Human | M | 22 y | Skin (Skn) | Hemangioma | Diseased | ||
| 1 | A9 | Human | M | 22 y | Subcutaneous tissue (Sct) | Neurofibroma | Tumor | ||
| 1 | A10 | Human | F | 44 y | Subcutaneous tissue (Sct) | Neurofibroma | Tumor | ||
| 1 | A11 | Human | F | 24 y | Scalp (Sca) | Neurofibroma | Tumor | ||
| 1 | A12 | Human | F | 67 y | Subcutaneous tissue (Sct) | Fibroma | Tumor | ||
| 1 | B1 | Human | M | 53 y | Skin, Penis (Skn) | Normal | Benign non-neoplastic | ||
| 1 | B2 | Human | F | 15 y | Skin, Leg (Skn) | Normal | Benign non-neoplastic | ||
| 1 | B3 | Human | M | 57 y | Skin, Wrist (Skn) | Ulcer, Chronic | Inflammatory | ||
| 1 | B4 | Human | F | 48 y | Skin, Ear (Skn) | Polyp | Tumor | ||
| 1 | B5 | Human | F | 20 y | Vulva (Vul) | Warts, HPV positive | Diseased | ||
| 1 | B6 | Human | M | 17 y | Penis (Pen) | Warts, HPV positive | Diseased | ||
| 1 | B7 | Human | M | 25 y | Skin (Skn) | Granuloma | Inflammatory | ||
| 1 | B8 | Human | M | 22 y | Skin (Skn) | Hemangioma | Diseased | ||
| 1 | B9 | Human | M | 22 y | Subcutaneous tissue (Sct) | Neurofibroma | Tumor | ||
| 1 | B10 | Human | F | 44 y | Subcutaneous tissue (Sct) | Neurofibroma | Tumor | ||
| 1 | B11 | Human | F | 24 y | Subcutaneous tissue (Sct) | Neurofibroma | Tumor | ||
| 1 | B12 | Human | F | 67 y | Subcutaneous tissue (Sct) | Fibroma | Tumor | ||
| 1 | C1 | Human | M | 50 y | Penis (Pen) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade I |
| 1 | C2 | Human | M | 59 y | Skin, Face (Skn) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade I |
| 1 | C3 | Human | M | 67 y | Penis (Pen) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade I |
| 1 | C4 | Human | M | 40 y | Penis (Pen) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade I |
| 1 | C5 | Human | F | 62 y | Skin (Skn) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade I |
| 1 | C6 | Human | F | 50 y | Skin, Leg (Skn) | Squamous cell carcinoma | Malignant | T2N0M0 | Grade I |
| 1 | C7 | Human | M | 34 y | Penis (Pen) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade I |
| 1 | C8 | Human | M | 79 y | Skin (Skn) | Squamous cell carcinoma | Malignant | T2N0M0 | Grade I |
| 1 | C9 | Human | F | 53 y | Skin, Head (Skn) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade I |
| 1 | C10 | Human | M | 47 y | Penis (Pen) | Squamous cell carcinoma | Malignant | T1N1M0 | Grade I |
| 1 | C11 | Human | M | 40 y | Penis (Pen) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade I |
| 1 | C12 | Human | M | 71 y | Penis (Pen) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade I |
| 1 | D1 | Human | M | 50 y | Penis (Pen) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade I |
| 1 | D2 | Human | M | 59 y | Skin, Face (Skn) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade I |
| 1 | D3 | Human | M | 67 y | Penis (Pen) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade I |
| 1 | D4 | Human | M | 40 y | Penis (Pen) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade I |
| 1 | D5 | Human | F | 62 y | Skin (Skn) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade I |
| 1 | D6 | Human | F | 50 y | Skin, Leg (Skn) | Squamous cell carcinoma | Malignant | T2N0M0 | Grade I |
| 1 | D7 | Human | M | 34 y | Penis (Pen) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade I |
| 1 | D8 | Human | M | 79 y | Skin (Skn) | Squamous cell carcinoma | Malignant | T2N0M0 | Grade I |
| 1 | D9 | Human | F | 53 y | Skin, Head (Skn) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade I |
| 1 | D10 | Human | M | 47 y | Penis (Pen) | Squamous cell carcinoma | Malignant | T1N1M0 | Grade I |
| 1 | D11 | Human | M | 40 y | Penis (Pen) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade I |
| 1 | D12 | Human | M | 71 y | Penis (Pen) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade I |
| 1 | E1 | Human | M | 57 y | Penis (Pen) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade I |
| 1 | E2 | Human | M | 61 y | Skin, Head (Skn) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade II |
| 1 | E3 | Human | F | 52 y | Skin, Head (Skn) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade II |
| 1 | E4 | Human | M | 53 y | Skin, Trunk (Skn) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade II |
| 1 | E5 | Human | M | 67 y | Skin, Trunk (Skn) | Squamous cell carcinoma | Malignant | T2N0M0 | Grade II |
| 1 | E6 | Human | F | 65 y | Vulva (Vul) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade II |
| 1 | E7 | Human | M | 36 y | Skin, Head (Skn) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade II |
| 1 | E8 | Human | M | 72 y | Skin, Head (Skn) | Squamous cell carcinoma | Malignant | T2N0M0 | Grade III |
| 1 | E9 | Human | F | 60 y | Skin, Leg (Skn) | Basal cell carcinoma | Malignant | T1N0M0 | |
| 1 | E10 | Human | M | 89 y | Skin, Face (Skn) | Basal cell carcinoma | Malignant | T1N0M0 | |
| 1 | E11 | Human | M | 80 y | Skin, Face (Skn) | Basal cell carcinoma | Malignant | T1N0M0 | |
| 1 | E12 | Human | F | 35 y | Scalp (Sca) | Neuroendocrine carcinoma | Malignant | T2N0M0 | |
| 1 | F1 | Human | M | 57 y | Penis (Pen) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade I |
| 1 | F2 | Human | M | 61 y | Skin, Head (Skn) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade II |
| 1 | F3 | Human | F | 52 y | Skin, Head (Skn) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade II |
| 1 | F4 | Human | M | 53 y | Skin, Trunk (Skn) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade II |
| 1 | F5 | Human | M | 67 y | Skin, Trunk (Skn) | Squamous cell carcinoma | Malignant | T2N0M0 | Grade II |
| 1 | F6 | Human | F | 65 y | Vulva (Vul) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade II |
| 1 | F7 | Human | M | 36 y | Skin, Head (Skn) | Squamous cell carcinoma | Malignant | T1N0M0 | Grade II |
| 1 | F8 | Human | M | 72 y | Skin, Head (Skn) | Squamous cell carcinoma | Malignant | T2N0M0 | Grade III |
| 1 | F9 | Human | F | 60 y | Skin, Leg (Skn) | Basal cell carcinoma | Malignant | T1N0M0 | |
| 1 | F10 | Human | M | 89 y | Skin, Face (Skn) | Basal cell carcinoma | Malignant | T1N0M0 | |
| 1 | F11 | Human | M | 80 y | Skin, Face (Skn) | Basal cell carcinoma | Malignant | T1N0M0 | |
| 1 | F12 | Human | F | 35 y | Subcutaneous tissue (Sct) | Neuroendocrine carcinoma | Malignant | T2N0M0 | |
| 1 | G1 | Human | M | 62 y | Skin, Groin (Skn) | Melanoma | Tumor | ||
| 1 | G2 | Human | M | 60 y | Skin, Chest (Skn) | Melanoma | Tumor | ||
| 1 | G3 | Human | M | 60 y | Skin, Foot (Skn) | Melanoma | Tumor | ||
| 1 | G4 | Human | F | 64 y | Scalp (Sca) | Plasmacytoma | Malignant | ||
| 1 | G5 | Human | F | 53 y | Skin, Face (Skn) | Fibrosarcoma | Malignant | ||
| 1 | G6 | Human | M | 44 y | Chest (Che) | Dermatofibrosarcoma protuberans | Malignant | ||
| 1 | G7 | Human | M | 45 y | Scalp (Sca) | Dermatofibrosarcoma protuberans | Malignant | ||
| 1 | G8 | Human | F | 64 y | Leg (Leg) | Malignant fibrous histiocytoma | Malignant | ||
| 1 | G9 | Human | F | 41 y | Subcutaneous tissue (Sct) | Dermatofibrosarcoma protuberans | Malignant | ||
| 1 | G10 | Human | F | 41 y | Lymph node, Neck (Lym) | Metastasis from squamous cell carcinoma | Metastatic | ||
| 1 | G11 | Human | M | 56 y | Vulva (Vul) | Metastatic adenocarcinoma | Metastatic | ||
| 1 | G12 | Human | F | 81 y | Chest (Che) | Metastasis from breast carcinoma | Metastatic | ||
| 1 | H1 | Human | M | 62 y | Skin, Groin (Skn) | Melanoma | Tumor | ||
| 1 | H2 | Human | M | 60 y | Skin, Chest (Skn) | Melanoma | Tumor | ||
| 1 | H3 | Human | M | 60 y | Skin, Foot (Skn) | Melanoma | Tumor | ||
| 1 | H4 | Human | F | 64 y | Subcutaneous tissue (Sct) | Plasmacytoma | Malignant | ||
| 1 | H5 | Human | F | 53 y | Subcutaneous tissue (Sct) | Possible fibrosarcoma | Tumor | ||
| 1 | H6 | Human | M | 44 y | Subcutaneous tissue (Sct) | Dermatofibrosarcoma protuberans | Malignant | ||
| 1 | H7 | Human | M | 45 y | Subcutaneous tissue (Sct) | Dermatofibrosarcoma protuberans | Malignant | ||
| 1 | H8 | Human | F | 64 y | Subcutaneous tissue (Sct) | Malignant fibrous histiocytoma | Malignant | ||
| 1 | H9 | Human | F | 41 y | Subcutaneous tissue (Sct) | Dermatofibrosarcoma protuberans | Malignant | ||
| 1 | H10 | Human | F | 41 y | Skin, Head (Skn) | Metastasis from squamous cell carcinoma | Metastatic | ||
| 1 | H11 | Human | M | 56 y | Subcutaneous tissue (Sct) | Metastatic adenocarcinoma | Metastatic | ||
| 1 | H12 | Human | F | 81 y | Skin, Head (Skn) | Metastasis from breast carcinoma | Metastatic |